AURA
Price
$5.40
Change
-$0.01 (-0.18%)
Updated
Nov 19 closing price
Capitalization
342.92M
131 days until earnings call
Intraday BUY SELL Signals
CGEM
Price
$8.45
Change
-$0.09 (-1.05%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
499.19M
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AURA vs CGEM

Header iconAURA vs CGEM Comparison
Open Charts AURA vs CGEMBanner chart's image
Aura Biosciences
Price$5.40
Change-$0.01 (-0.18%)
Volume$174.35K
Capitalization342.92M
Cullinan Therapeutics
Price$8.45
Change-$0.09 (-1.05%)
Volume$9.3K
Capitalization499.19M
AURA vs CGEM Comparison Chart in %
AURA
Daily Signal:
Gain/Loss:
CGEM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AURA vs. CGEM commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and CGEM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (AURA: $5.40 vs. CGEM: $8.45)
Brand notoriety: AURA and CGEM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 63% vs. CGEM: 79%
Market capitalization -- AURA: $342.92M vs. CGEM: $499.19M
AURA [@Biotechnology] is valued at $342.92M. CGEM’s [@Biotechnology] market capitalization is $499.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 1 FA rating(s) are green whileCGEM’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 1 green, 4 red.
  • CGEM’s FA Score: 1 green, 4 red.
According to our system of comparison, CGEM is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 3 TA indicator(s) are bullish while CGEM’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 3 bullish, 5 bearish.
  • CGEM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -3.05% price change this week, while CGEM (@Biotechnology) price change was +1.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

AURA is expected to report earnings on Mar 31, 2026.

CGEM is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($499M) has a higher market cap than AURA($343M). CGEM YTD gains are higher at: -30.624 vs. AURA (-34.307). AURA has higher annual earnings (EBITDA): -107.51M vs. CGEM (-234.39M). CGEM has more cash in the bank: 265M vs. AURA (177M). CGEM has less debt than AURA: CGEM (1.52M) vs AURA (18.1M). AURA (0) and CGEM (0) have equivalent revenues.
AURACGEMAURA / CGEM
Capitalization343M499M69%
EBITDA-107.51M-234.39M46%
Gain YTD-34.307-30.624112%
P/E RatioN/AN/A-
Revenue00-
Total Cash177M265M67%
Total Debt18.1M1.52M1,192%
TECHNICAL ANALYSIS
Technical Analysis
AURACGEM
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 15 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signal:
Gain/Loss:
CGEM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VNSYX24.450.14
+0.58%
Natixis Vaughan Nelson Select Y
PMYTX48.760.23
+0.47%
Putnam Core Equity Fund R6
ECCPX49.32N/A
N/A
Eaton Vance Tax-Managed Multi-Cap Gr C
SLPSX92.35N/A
N/A
ProFunds Small Cap Svc
PGHAX71.28-0.21
-0.29%
Putnam Global Health Care R6

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with IDYA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-1.05%
IDYA - CGEM
49%
Loosely correlated
-1.72%
DNLI - CGEM
47%
Loosely correlated
-3.20%
AURA - CGEM
46%
Loosely correlated
-0.18%
TRDA - CGEM
46%
Loosely correlated
-0.91%
BDTX - CGEM
45%
Loosely correlated
-2.02%
More